Rheumatic syndromes: Clues to occult neoplasia

https://doi.org/10.1016/S0049-0172(99)80037-7Get rights and content

Abstract

Objectives:

Rheumatic disorders associated with cancer include a variety ofconditions, most of which have no features distinguishing them from idiopathic rheumatic disorders. It is generally held that an extensive search for occult malignancy in most rheumatic syndromes is not recommended unless accompanied by specific findings suggestive of malignancy. The objective of this review are to identify rheumatic syndromes associated with cancer, to call attention to features that may suggest the presence of a hidden cancer, and to examine the role to additional clinical and laboratory data as clues to the possible neoplastic cause of those syndromes.

Methods:

A MEDLINE search of the literature dealing with cancer-associated rheumatic syndromes was conducted.

Results:

Review of the literature identified significant progress in this area.First, the association of malignancy with certain rheumatic syndromes was convincingly established, such as asymmetric polyarthritis presenting in the elderly with an explosive onset, rheumatoid arthritis with monoclonal gammopathy, Sjögren's syndrome with monoclonality, hypertrophic osteoarthropathy, dermatomyositis, polymyalgia rheumatica with atypical features, Lambert-Eaton myasthenic syndrome, palmar fasciitis and arthritis, eosinophilic fasciitis poorly responsive to corticosteroid therapy, erythema nodosum lasting more than 6 months, and onset of Raynaud's phenomenon or cutaneous leukocytoclastic vasculitis after age 50 years. Second, the list of cancer-associated rheumatic syndromes was extended by including additional entities such as benign edematous polysynovitis, sacroiliitis, adult-onset Still's disease, dermatomyositis sine myositis, systemic sclerosis, Sweet's syndrome, osteomalacia, skeletal hyperostosis, antiphospholipid syndrome, and essential mixed cryoglobulinemia. Third, evidence was provided substantiating that certain longstanding rheumatic syndromes, in particular rheumatoid arthritis, Felty's syndrome, Sjögren's syndrome, dermatomyositis, systemic sclerosis, systemic lupus erythematosus, and temporal arteritis behave like “premalignant conditions.” Fourth, it was shown that the recognized tumor markers alpha-fetoprotein, prostate-specific antigen, CA-125, CA 19-9, and CA-3 have low sensitivity and specificity in screening for occult cancer in a population of rheumatic patients, whereas the presence of a monoclonal gammopathy in rheumatoid arthritis and the monoclonal antibody 17-109 in Sjögren's syndrome are reliable signs of malignant transformation.

Conclusions:

The presence of specific rheumatic syndromes and certain clinical and laboratory findings may justify a workup for hidden cancer. Studies of the epidemiology of the cancer-associated rheumatic syndromes and evaluation of the validity of aforementioned clues in prospectives studies are goals for future investigations.

References (112)

  • PfitzenmeyerP. et al.

    Current aspects of paraneoplastic acute polyarthritis

    Rev Med Interne

    (1992)
  • DalyB.D.

    Thoracic metastases from nasopharyngeal carcinoma presenting as hypertrophic pulmonary osteoarthropathy: scimigraphic and CT findings

    Clin Radiol

    (1995)
  • StoneO.J.

    Dermatomyositis/polymyositis associated with internal malignancy: a consequence of how neoplasms alter generalized extracellular matrix in the host

    Med Hypotheses

    (1993)
  • ShielW.C. et al.

    Palmar fasciitis and arthritis with ovarian and non-ovarian carcinomas: new syndrome

    Am J Med

    (1985)
  • LakhanpalS. et al.

    Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases

    Semin Arthritis Rheum

    (1988)
  • NaschitzJ.E. et al.

    Arterial occlusive disease in occult cancer

    Am Heart J

    (1992)
  • KurzrockR. et al.

    Vasculitis and cancer

    Clin Dermatol

    (1993)
  • ButlerR.C. et al.

    Paraneoplastic rheumatic disorders: a review

    J R Soc Med

    (1987)
  • BrooksP.M.

    Rheumatic manifestations of neoplasia

    Curr Opin Rheum

    (1992)
  • MertzL.E. et al.

    Vasculitis associated with malignancy

    Curt Opin Rheum

    (1992)
  • Avina-ZubietaJ.A. et al.

    Rheumatic manifestations of malignancy

    Curr Opin Rheum

    (1996)
  • CarsonsS.

    The association of malignancy with rheumatic and connective tissue diseases

    Semin Oncol

    (1997)
  • JohnW.J. et al.

    Paraneoplastic syndromes

  • HallT.C.

    Paraneoplastic syndromes: mechanisms

    Semin Oncol

    (1997)
  • NathansonL. et al.

    Introduction: paraneoplastic syndromes

    Semin Oncol

    (1997)
  • LennonV.A. et al.

    Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes

    N Engl J Med

    (1995)
  • AbdouN.I. et al.

    Suppressor T-cell disfunction and anti-suppressor antibody in active early rheumatoid arthritis

    J Rheumatol

    (1981)
  • StephenR.S. et al.

    The associations and relationships of congenital immunodeficiency states and autoimmune phenomena

    Semin Arthritis Rheum

    (1979)
  • TzioufasA.G. et al.

    Lymphoid malignancy and monoclonal proteins

  • ShokriF. et al.

    Lymphoproliferation in primary Sjogren's syndrome: evidence of selective expansion of a B-cell sunset characterized by the expression of cross-reactive idiotypes

    Arthritis Rheum

    (1993)
  • GuoK. et al.

    Defective repair of 0-6-methylguanide-DNA in primary Sjogren's syndrome patients predisposed to lymphoma

    Ann Rheum Dis

    (1995)
  • ZantosD. et al.

    The overall and temporal association of cancer with polymyositis and dermatomyositis

    J Rheumatol

    (1994)
  • GridleyG. et al.

    Incidence of cancer among men with Felty's syndrome

    Ann Intern Med

    (1994)
  • RosenthalA.K. et al.

    Scleroderma and malignancy: an epidemiologic study

    Ann Rheum Dis

    (1993)
  • RosenthalA. et al.

    Incidence of cancer among patients with systemic sclerosis

    Cancer

    (1995)
  • Abu-ShakraM. et al.

    Malignancy in systemic lupus erythematosus

    Arthritis Rheum

    (1996)
  • RadisC.D. et al.

    Effects of cyclophosphamide on the development of malignancy and long-term survival of patients with rheumatoid arthritis: a 20-year follow-up study

    Arthritis Rheum

    (1995)
  • KamelO.W. et al.

    Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis

    N Engl J Med

    (1993)
  • ArenalloF. et al.

    Malignancies in rheumatoid arthritis patients treated with cyclosporin A

    Br J Rheumatol

    (1993)
  • Sanchez-GuerreroJ. et al.

    Vasculitis as a paraneoplastic syndrome: report of 11 cases and review of the literature

    J Rheumatol

    (1990)
  • MedsgerT.A. et al.

    Palmar fasciitis and polyarthrifis associated with ovarian carcinoma

    Ann Intern Med

    (1982)
  • BarnesB.E.

    Dermatomyositis and malignancy: a review of the literature

    Ann Intern Med

    (1976)
  • BohnS. et al.

    Erythema nodosum: 112 cases: epidemiology, clinical aspects and histopathology

    Schweiz Med Wochenschr

    (1997)
  • AttiasD. et al.

    Acute neutrophilic myositis in Sweet's syndrome: late phase transformation into fibrosing myositis and panniculitis

    Hum Pathol

    (1995)
  • NaschitzJ.E. et al.

    Cancer-associated fasciitis panniculitis

    Cancer

    (1994)
  • OlivoD. et al.

    Concurrence of benign edematous polysynovitis in the elderly (RS3PE syndrome) and endometrial adenocarcinoma

    Scand J Rheumatol

    (1997)
  • HunphreyS.M. et al.

    Metastatic adenocarcinoma mimicking unilateral sacroiliitis

    J Rheumatol

    (1995)
  • ScutelariP.N. et al.

    Association between diffuse skeletal hyperostosis and multiple myeloma

    Skeletal Radiol

    (1995)
  • LaCivitaL. et al.

    Mixed cryoglobulinemia as a possible paraneoplastic disorder

    Arthritis Rheum

    (1995)
  • WhitmoreS.E. et al.

    Dermatomyositis sine myositis: association with malignancy

    J Rheumatol

    (1996)
  • Cited by (153)

    • The Relationship Between Rheumatologic Disorders and Malignancies

      2018, Rheumatic Disease Clinics of North America
      Citation Excerpt :

      However, tumor markers such as α-fetoprotein, prostate-specific antigen, CA-125, CA 19-9, and CA-3 have low sensitivity and specificity in screening for occult cancer in these patients. On the other hand, the presence of a monoclonal gammopathy in RA and the finding of monoclonal antibody 17-9 in Sjögren syndrome have been described as potential signs of malignant transformation.6 The association of malignancies with RA is somewhat controversial.

    • Rheumatologic Manifestations of Malignancy

      2017, Clinics in Geriatric Medicine
    • Antiphospholipid Syndrome Associated With Malignancies

      2017, Handbook of Systemic Autoimmune Diseases
    View all citing articles on Scopus
    View full text